Department of Pharmacy, University of Washington, Seattle, USA.
Health Aff (Millwood). 2010 Oct;29(10):1812-7. doi: 10.1377/hlthaff.2010.0692.
The Patient Protection and Affordable Care Act established a new Patient-Centered Outcomes Research Institute to identify and address research priorities for comparative effectiveness research. Among its many responsibilities, the institute has been charged with setting priorities, developing methodological standards, and communicating research results to decision makers. In this paper we consider how the institute can support the different standards for acceptable evidence used by various government agencies, providers, patients, and other decision makers. We argue that the public interest will best be served if the institute develops a balanced and flexible approach to deciding which types of studies to fund.
《患者保护与平价医疗法案》设立了一个新的以患者为中心的成果研究机构,以确定和解决比较有效性研究的优先事项。该机构的众多职责之一是确定优先事项、制定方法学标准,并将研究结果传达给决策者。在本文中,我们考虑该机构如何支持不同政府机构、提供者、患者和其他决策者使用的不同可接受证据标准。我们认为,如果该机构制定出一种平衡和灵活的方法来决定资助哪些类型的研究,那么将最符合公众利益。